overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adult males on pharmacological therapy for benign prostatic hyperplasia (BPH). The Sumitomo ...

Sumitomo Pharma America, Inc. (SMPA) presented new, positive data from the COURAGE Phase 3 open-label extension study of vibegron (GEMTESA®) in men living with overactive bladder (OAB) and receiving ...

Prostadine's Advanced Liquid Formula Combines Plant-Based Detox and Hormonal Balance to Help Men Over 40 Improve Prostate ...

Five years after treatment with the Optilume BPH catheter system, urinary flow rate (Qmax) improved by 63% and post-void residual volume (PVR) remained substantially lower than baseline.

A trial of a permanent prostatic urethral stent for treatment of BPH demonstrated early success. A novel prostatic urethral stent can reduce lower urinary tract symptoms (LUTS) in men with benign ...

A postmarketing study showed that the Optilume BPH system improved the flow of urine while leaving sexual function unchanged in men with benign prostatic hyperplasia (BPH), researchers reported at ...

Not too long ago, men who wanted relief from BPH had one main option: surgery. In recent years, that’s changed. Drugmakers have come out with a number of medicines that give you more choices to ...

Medical device company Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement for individuals with benign prostatic hyperplasia (BPH) in the ZEST ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...

King Charles III has given his first comments about the "frightening experience" of being diagnosed with cancer and his ...

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with ...